AGP Executive Report
Last update: 5 hours agoHepatitis B Vaccine Trial: A Danish university has approved a study in Guinea-Bissau that plans to withhold the birth-dose vaccine from half of 14,000 newborns for six weeks. Guinea-Bissau officials have also reportedly approved the trial, which was previously paused amid ethical objections. The CDC has reportedly set aside $1.6 million to fund it. Health experts warn that delaying a proven vaccine could leave babies vulnerable to lifelong infection; nearly one in five people in Guinea-Bissau has hepatitis B.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.